NCT04703920 |
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer |
NCT05457842 |
A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery |
NCT05394259 |
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer |
NCT04930783 |
NeoVax + CDX-301 and Nivolumab in Melanoma |
NCT05061017 |
Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) |
NCT03929029 |
Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma |
NCT04117087 |
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer |
NCT04655157 |
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma |
NCT05057715 |
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer |
NCT05034536 |
Pembrolizumab + Infliximab for Metastatic Melanoma |
NCT03104439 |
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer |
NCT01638676 |
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients |
NCT04598009 |
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma |
NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
NCT04315233 |
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics |
NCT03454035 |
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
NCT04024878 |
NeoVax With Nivolumab in Patients With Ovarian Cancer |
NCT04996823 |
Axitinib + Ipilimumab in Advanced Melanoma |
NCT05523440 |
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation |
NCT04339140 |
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer |
NCT04611568 |
War on Melanoma™ Public Health & Education Campaign |
NCT04552223 |
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma |
NCT05308901 |
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma |
NCT02621021 |
A Prospective Randomized and Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab |
NCT04971499 |
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma |
NCT05130177 |
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma |
NCT04581382 |
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma |
NCT03950635 |
Dietary Intervention in Patients With a History of Melanoma |
NCT04570553 |
Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers |
NCT03311308 |
A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma |
NCT04930991 |
High Dose Omeprazole in Patients With Pancreatic Cancer |
NCT03757689 |
Neoadjuvant PD-1 Blockade in Patients With Stage IIB/C Melanoma |
NCT04464759 |
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma |
NCT02706353 |
APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma |
NCT05272462 |
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer |
NCT04526730 |
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients |
NCT04020809 |
Neoadjuvant Atezolizumab in Cutaneous Melanoma |
NCT03935256 |
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer |
NCT05384496 |
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma |
NCT03743766 |
Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting |
NCT05640193 |
Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Asymptomatic Melanoma Brain Metastases |
NCT01972919 |
Magnetic Resonance (MR) Guided, Dose-Escalated Radiation Therapy (RT) + Chemotherapy in Pancreatic Cancer |
NCT05089370 |
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma |
NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
NCT05029154 |
Exercise Preconditioning in Ovarian Cancer |
NCT04493203 |
Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma |
NCT04688658 |
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma |
NCT04513028 |
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma |
NCT04048278 |
Lidocaine Infusion in Pancreatic Cancer |
NCT05546827 |
PRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma |
NCT03925350 |
Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation |
NCT05047926 |
Prehabilitation for Advanced Ovarian Cancer Patients |
NCT03957551 |
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma |
NCT02143050 |
Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients |
NCT05438927 |
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer |
NCT05524935 |
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma |
NCT05675059 |
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients |
NCT03322995 |
Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients With Localized Pancreatic Cancer |
NCT04476537 |
RNA Precision Oncology in Advanced Pancreatic Cancer |
NCT05415917 |
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy |
NCT05077280 |
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma |
NCT05004025 |
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma |
NCT05200143 |
Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma |
NCT05483075 |
Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer |
NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
NCT04177810 |
Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer |
NCT04187833 |
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes |
NCT04970368 |
Comparison of Nodal Staging in Endometrial Cancer |
NCT03492164 |
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer |
NCT05498792 |
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma |
NCT03256201 |
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes |
NCT04390880 |
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer |
NCT05360732 |
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients |
NCT05170334 |
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma |
NCT04927013 |
Connecting Families to Overcome Ovarian Cancer |
NCT04783467 |
Time Restricted Eating (TRE) Among Endometrial Cancer Patients |
NCT04683653 |
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer |
NCT04820179 |
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer |
NCT04025229 |
High Intensity Interval Training in Endometrial Cancer |
NCT04458402 |
Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer |
NCT03287271 |
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK |
NCT04473833 |
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer |
NCT04844970 |
Anamorelin Study for Advanced Pancreatic Cancer |
NCT04720417 |
Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma |
NCT04386993 |
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer |
NCT04608409 |
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer |
NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
NCT04427306 |
Neoadjuvant T-VEC in High Risk Early Melanoma |
NCT04594187 |
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma |
NCT05123807 |
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) |
NCT05189457 |
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer |
NCT05586360 |
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer |
NCT03832361 |
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer |
NCT03385486 |
Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors |
NCT03232164 |
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer |
NCT05098210 |
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer |
NCT02672098 |
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer |
NCT04984343 |
Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer |
NCT05229588 |
Lurbinectedin in Patients With Advanced Pancreatic Cancer With DNA Repair Mutations |
NCT03467516 |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma |
NCT03617328 |
Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma |
NCT03323944 |
CAR T Cell Immunotherapy for Pancreatic Cancer |
NCT05526248 |
A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide |
NCT03541928 |
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery |
NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
NCT03674814 |
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer |
NCT04346225 |
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer |
NCT05470036 |
Improving Germline Testing in At-Risk Patients With Prostate Cancer |
NCT04700332 |
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer |
NCT04928508 |
Advanced or Recurrent Ovarian, Cervical, and Endometrial Cancer Treated With SHetA2 |
NCT04903119 |
Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma |
NCT02128100 |
Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer |
NCT02340117 |
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer |
NCT02282137 |
68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer |
NCT04633902 |
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation |
NCT03783325 |
Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma |
NCT03743298 |
Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma |
NCT03951831 |
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer |
NCT03617679 |
Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer |
NCT03646617 |
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma |
NCT05470283 |
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma |
NCT05496686 |
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma |
NCT03991130 |
High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma |
NCT04093323 |
Polarized Dendritic Cell (aDC1) Vaccine, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma |
NCT04741997 |
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma |
NCT04562129 |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients |
NCT05318131 |
Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer |
NCT05289193 |
CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma |
NCT03955978 |
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer |
NCT03734692 |
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer |
NCT03679260 |
Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance |
NCT04665947 |
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer |
NCT02331134 |
Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer |
NCT04019964 |
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer |
NCT05311527 |
UroLift System With SAbR for Prostate Cancer and BPH |
NCT04364230 |
Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) |
NCT04981223 |
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging |
NCT05056896 |
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension |
NCT05361915 |
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer |
NCT04457089 |
Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer |
NCT05454488 |
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
NCT05345444 |
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) |
NCT03223779 |
Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer |
NCT05477823 |
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer |
NCT04082962 |
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma |
NCT05375539 |
AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients |
NCT05099679 |
Pilot Study for Optimizing Mental Wellbeing & Heart Health for Black Patients w/ Prostate Cancer |
NCT03694834 |
Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer |
NCT04635059 |
Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer |
NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
NCT04842890 |
Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer |
NCT05608291 |
A Study to Evaluate the Superiority of the Fianlimab and Cemiplimab Combination Compared to Pembrolizumab in Adult and Adolescent Patients With Completely Resected High-Risk Skin Cancer |
NCT04116775 |
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. |
NCT04552509 |
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer |
NCT04705038 |
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments |
NCT04349501 |
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) |
NCT05224869 |
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer |
NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
NCT04037358 |
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers |
NCT03665922 |
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer |
NCT03392181 |
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer |
NCT05608694 |
MRI Screening in Men at High Risk of Developing Prostate Cancer |
NCT04989946 |
Androgen Deprivation, With or Without pTVG-AR, and With or Without Nivolumab, in Patients With Newly Diagnosed, High-Risk Prostate Cancer |
NCT03971591 |
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors |
NCT03275857 |
Cisplatin in Castration Resistant Prostate Cancer |
NCT05068752 |
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer |
NCT04298983 |
Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer |
NCT05417386 |
FOLFIRINOX + NIS793 in Pancreatic Cancer |
NCT03999151 |
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II) |
NCT03585660 |
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy |
NCT04147806 |
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer |
NCT03315871 |
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer |
NCT05026983 |
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases |
NCT02705196 |
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer |
NCT02016248 |
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer |
NCT04301414 |
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer |
NCT05628363 |
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer |
NCT05141643 |
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer |
NCT03663218 |
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) |
NCT04904120 |
Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy |
NCT04402151 |
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer |
NCT03089203 |
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer |
NCT04243941 |
PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer |
NCT02933255 |
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer |
NCT03753243 |
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer |
NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
NCT04422132 |
Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks |
NCT05011188 |
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer |
NCT05013216 |
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer |
NCT02207465 |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
NCT02600156 |
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors |
NCT05111353 |
Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery |
NCT05304962 |
First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
NCT03596073 |
Topical Calcipotriene Treatment for Breast Cancer Immunoprevention |
NCT01607008 |
MRI for Assessing Prostate Cancer Response |
NCT03495427 |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores |
NCT03932409 |
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer |
NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
NCT02946996 |
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy |
NCT05156905 |
Study of Docetaxel Combined With Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer |
NCT02382549 |
A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib |
NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
NCT03087903 |
A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA |
NCT05617040 |
Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer |
NCT05393713 |
Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for the Treatment of In-Transit Melanoma, The Sofusa-2 Study |
NCT04220983 |
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer |
NCT02926729 |
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy |
NCT04401995 |
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab |
NCT04536077 |
Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients |
NCT00588185 |
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer |
NCT03861975 |
Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening |
NCT04692675 |
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer |
NCT01088789 |
A Trial of Boost Vaccinations of Pancreatic Tumor Cell Vaccine |
NCT05497778 |
A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer. |
NCT03486821 |
Ultra-hypofractionated Radiation in Prostate Cancer |
NCT05073432 |
Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer |
NCT05504707 |
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer |
NCT05628883 |
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma |
NCT04670068 |
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian |
NCT02420977 |
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer |
NCT03769155 |
VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma |
NCT03652428 |
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC) |
NCT05077098 |
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer |
NCT04743999 |
Evaluation of Quality of Life Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma |
NCT04502602 |
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer |
NCT05558956 |
Total Body PET-CT Imaging of Prostate Cancer Using Illuccix |
NCT03765983 |
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases |
NCT05074290 |
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients |
NCT02040610 |
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer |
NCT05086250 |
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer |
NCT03553602 |
BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy |
NCT04651452 |
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors |
NCT04158635 |
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer |
NCT03860987 |
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer |
NCT05014776 |
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer |
NCT05327452 |
Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study |
NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
NCT05051631 |
BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity |
NCT04754191 |
Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT05553639 |
HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer |
NCT05219500 |
Targeted Alpha Therapy With 225Actinium-PSMA-I&T of Castration-resISTant Prostate Cancer (TATCIST). |
NCT05528133 |
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer |
NCT05085548 |
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies |
NCT04109729 |
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer |
NCT03763838 |
Acupressure for Fatigue in Ovarian Cancer Survivors |
NCT04477512 |
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial) |
NCT03543969 |
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma |
NCT04206319 |
Radium-223 in Biochemically Recurrent Prostate Cancer |
NCT05472064 |
Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black Women |
NCT05424783 |
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC) |
NCT04132505 |
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer |
NCT04883814 |
18F-fluoroestradiol (FES) PET/CT for Breast Cancer |
NCT03564782 |
Examining Bioactivity of PVSRIPO in Invasive Breast Cancer |
NCT04158245 |
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies |
NCT03761706 |
Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging |
NCT04420702 |
Diffusion Basis Spectrum Imaging of the Prostate |
NCT05324098 |
Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy |
NCT05263492 |
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer |
NCT04483414 |
68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer |
NCT04786600 |
A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial |
NCT03965481 |
PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer |
NCT04228055 |
Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2) |
NCT04270149 |
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer |
NCT05025735 |
Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer |
NCT04452357 |
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer |
NCT05502315 |
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer |
NCT02515513 |
The Role of Muscle Cachexia in Pancreatic Cancer |
NCT05378464 |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
NCT04848051 |
Implementing Fit Kit Colorectal Cancer (CRC) Screening in High Risk Populations |
NCT05064085 |
Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer |
NCT04748380 |
Shared Decision-making and Colorectal Cancer Screening |
NCT02564848 |
Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65 |
NCT05549505 |
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery |
NCT03668431 |
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer |
NCT04450264 |
Increasing African Immigrant Women's Participation in Breast Cancer Screening |
NCT05576077 |
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors |
NCT05338307 |
Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention |
NCT05419817 |
Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System |
NCT03742245 |
Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer |
NCT04465500 |
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer |
NCT04728633 |
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases |
NCT04967196 |
Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma |
NCT02643667 |
Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer |
NCT05343013 |
TAS-102 in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy |
NCT04336397 |
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People |
NCT03694756 |
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer |
NCT04940442 |
Outreach and Choice in Colorectal Cancer Screening |
NCT00734838 |
Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy |
NCT04282967 |
Streaming Web-based Exercise At Home: A Pilot Study |
NCT05337280 |
OA for Breast Cancer NAC Response |
NCT05350501 |
EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer |
NCT03321188 |
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients |
NCT05052723 |
Cabozantinib and Pembrolizumab in Metastatic Pancreas |
NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
NCT05361798 |
T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy |
NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
NCT05092763 |
Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer |
NCT04474184 |
Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates |
NCT05446129 |
A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery |
NCT05081193 |
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer |
NCT05607095 |
Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma |
NCT05113485 |
UCLA Breast Cancer Survivor Health Promotion Research Study |
NCT04965064 |
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling |
NCT05127850 |
MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer |
NCT05000502 |
Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations |
NCT05334732 |
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters) |
NCT05483283 |
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care |
NCT03312972 |
Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy |
NCT03496805 |
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy |
NCT05623488 |
CAR T Cells in Mesothelin-Expressing Breast Cancer |
NCT05036226 |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
NCT05444231 |
An Online Research Study: BrainHealth in Breast Cancer Survivors |
NCT05336786 |
An Imaging Agent (Perflutren Lipid Microspheres) With Ultrasound for Imaging of Prostate Cancer |
NCT03253744 |
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy |
NCT04013568 |
Exercise Post-Diagnosis of Breast Cancer |
NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
NCT05609435 |
Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer |
NCT03643861 |
RAD 1802: Pilot Trial of Dose Adapted Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI) |
NCT05265715 |
A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors |
NCT05704842 |
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy |
NCT04628988 |
A Study of CC-90011 and Comparators in Participants With Prostate Cancer |
NCT05130840 |
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer |
NCT03933670 |
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance |
NCT05140252 |
Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid |
NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer |
NCT00703105 |
Ovarian Dendritic Cell Vaccine Trial |
NCT05636943 |
Couples' QOL in Metastatic Breast Cancer |
NCT04141995 |
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer |
NCT03272334 |
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer |
NCT05470699 |
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer |
NCT04508764 |
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome |
NCT05704933 |
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases |
NCT04493034 |
Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer |
NCT04594473 |
A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors |
NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
NCT04633252 |
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer |
NCT03324425 |
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer |
NCT03400215 |
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer |
NCT05259410 |
Time Restricted Eating During Chemotherapy for Breast Cancer |
NCT03820141 |
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer |
NCT05042687 |
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer |
NCT02035787 |
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients |
NCT04040569 |
A Phase I Dose Escalation Study of Single Fraction Ablative Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer |
NCT05243641 |
Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test |
NCT03822494 |
CyberKnife Dose Escalation Prostate Cancer Trial |
NCT04354675 |
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer |
NCT04495257 |
A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC) |
NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
NCT03712813 |
Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors |
NCT04796220 |
Focused Ultrasound and Gemcitabine in Breast Cancer |
NCT04763980 |
Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer |
NCT05160597 |
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy |
NCT05067777 |
Massage for Prostate Cancer-Related Fatigue, mPROSTATE Study |
NCT04805333 |
Phase 1 Dose Escalation of ArtemiCoffee |
NCT03998618 |
Telephone Support for Metastatic Breast Cancer Patients |
NCT02958774 |
Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation |
NCT03413995 |
Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations |
NCT05176470 |
Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients |
NCT03632941 |
A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer |
NCT03802851 |
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer |
NCT04373031 |
Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer |
NCT04337580 |
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer |
NCT04562233 |
Breast Cancer and Resistance Exercise Program |
NCT03699995 |
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma |
NCT04990921 |
Study of Palliative Radiation Combined With Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
NCT03824145 |
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer |
NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
NCT02706561 |
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery |
NCT05169957 |
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) |
NCT04243616 |
Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer |
NCT03808077 |
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer |
NCT04020575 |
Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) |
NCT04427527 |
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia |
NCT05588453 |
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain |
NCT03436745 |
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females |
NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
NCT04857502 |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
NCT04444622 |
Immunotherapy for Third Line Metastatic Colorectal Cancer |
NCT04957290 |
A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors |
NCT02807597 |
Real-time Intraoperative Breast Cancer Visualization for Margin Assessment |
NCT04364672 |
Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Breast Cancer |
NCT05216120 |
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas |
NCT03492671 |
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer |
NCT05305924 |
Fulvestrant+Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
NCT05676463 |
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer |
NCT04266431 |
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression |
NCT03873818 |
Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain |
NCT01913106 |
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
NCT03981718 |
Adipose-Induced Regeneration of Breast Skin to Treat Post-Mastectomy Radiation Injury in Breast Cancer Patients |
NCT04763174 |
An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE) |
NCT05155033 |
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma |
NCT04458532 |
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer |
NCT04331067 |
Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer |
NCT04205786 |
Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer |
NCT04332588 |
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI |
NCT04709276 |
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer |
NCT02732171 |
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer |
NCT05654532 |
Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer |
NCT04389281 |
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma |
NCT03032406 |
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer |
NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
NCT04853043 |
Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer |
NCT04748042 |
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) |
NCT05029999 |
CD40 Agonist, Flt3 Ligand, and Chemotherapy in Triple Negative Breast Cancer |
NCT04427293 |
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC) |
NCT03711890 |
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer |
NCT02227654 |
Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors |
NCT05187832 |
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer |
NCT04450706 |
Functional Precision Oncology for Metastatic Breast Cancer |
NCT05571839 |
A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors |
NCT05071937 |
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer |
NCT04941430 |
7T MRI Scan for the Early Detection of Melanoma Brain Metastases |
NCT05351424 |
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc |
NCT04273555 |
Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging |
NCT04190056 |
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer |
NCT04751929 |
Abemaciclib With or Without Atezolizumab for mCRPC |
NCT05411094 |
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer |
NCT05423730 |
Alcohol and Breast Cancer (ABC) Trial |
NCT03962647 |
A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer |
NCT04846478 |
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC |
NCT05082025 |
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations |
NCT04352777 |
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer |
NCT05479578 |
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer |
NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
NCT04090528 |
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer |
NCT04568616 |
Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) |
NCT04272801 |
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer |
NCT04542135 |
Sulindac and Breast Density in Women at Risk of Developing Breast Cancer |
NCT04895761 |
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer |
NCT02935205 |
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer |
NCT04698564 |
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging |
NCT03043794 |
Study of Stereotactic Radiotherapy for Breast Cancer |
NCT02613650 |
A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers |
NCT05010200 |
The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. |
NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
NCT05225363 |
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer |
NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
NCT05233800 |
mHealth for Breast Cancer Survivors With Insomnia |
NCT05011799 |
Health Education Intervention for Genetic Evaluation for Prostate Cancer Among African American Men, The Peer Genetic Study |
NCT04725903 |
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer |
NCT04965688 |
Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition |
NCT04645680 |
Effect of Diet on the Immune System in Patients With Stage III-IV Melanoma Receiving Immunotherapy, DIET Study |
NCT03801369 |
Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer |
NCT05245006 |
PET Imaging Study of 89Zr-DFO-YS5 |
NCT05014295 |
Patient Recall of Cancer Screening and Diagnosis |
NCT05139368 |
Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer |
NCT05077137 |
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy |
NCT04837118 |
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study |
NCT03601923 |
Niraparib in Patients With Pancreatic Cancer |
NCT03671811 |
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy |
NCT04753359 |
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer |
NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
NCT05472792 |
Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN) |
NCT05576896 |
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory |
NCT04134884 |
Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer |
NCT03835819 |
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) |
NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I, II, and IV Melanoma |
NCT02435472 |
Active Surveillance Exercise Clinical Trial |
NCT03889795 |
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors |
NCT04634539 |
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer |
NCT05013255 |
Pioglitazone Therapy Targeting Fatigue in Breast Cancer |
NCT03085043 |
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer |
NCT05132296 |
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer |
NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
NCT01955460 |
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma |
NCT04267796 |
Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women |
NCT04469764 |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
NCT04119024 |
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma |
NCT04703426 |
Sargramostim (GM-CSF) + PD-1 |
NCT04245176 |
Genetic Testing for All Breast Cancer Patients (GET FACTS) |
NCT05055843 |
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer |
NCT04721886 |
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer |
NCT04913064 |
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer |
NCT04375527 |
Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma |
NCT05325151 |
Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer |
NCT04251416 |
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma |
NCT03719131 |
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy |
NCT05325632 |
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab |
NCT03945721 |
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients |
NCT03580499 |
Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy |
NCT02070705 |
DCE MRI in Patients With Pancreatic Cancer |
NCT05036109 |
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease |
NCT05081492 |
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer |
NCT04720209 |
Taking AIM at Breast Cancer |
NCT04098081 |
1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma |
NCT05408260 |
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer |
NCT04886986 |
225Ac-J591 Plus 177Lu-PSMA-I&T for mCRPC |
NCT03679559 |
Exercise in Improving Health and Quality of Life in Breast Cancer Survivors |
NCT04256941 |
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study |
NCT05200442 |
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer |
NCT04896073 |
Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) |
NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
NCT03675893 |
Abemaciclib With Letrozole in Recurrent or Persistent Endometrial Cancer |
NCT04506567 |
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC |
NCT04207255 |
Addition of Opaganib to Androgen Antagonists in Patients With mCRPC |
NCT05198843 |
Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body |
NCT05391126 |
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
NCT04139902 |
Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma |
NCT05225428 |
Video Education With Result Dependent dIsclosure |
NCT03977233 |
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer |
NCT02600949 |
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer |
NCT04821375 |
Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers |
NCT03657108 |
CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation |
NCT04674306 |
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer |
NCT04336943 |
Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load |
NCT05305365 |
Study Assessing QBS72S For Treating Brain Metastases of Breast Cancer |
NCT03439735 |
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC |
NCT05256745 |
RAGE Inhibition to Decrease Therapy Cardiotoxicity in Women With Early Breast Cancer |
NCT04482244 |
RCT of CBD for Anxiety in Advanced Breast Cancer |
NCT04363164 |
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression |
NCT03703492 |
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS |
NCT04533763 |
Living WELL: A Web-Based Program for Ovarian Cancer Survivors |
NCT04866810 |
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN) |
NCT05653752 |
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer |
NCT02681549 |
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer |
NCT05524584 |
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer |
NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
NCT04620603 |
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer |
NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
NCT05150652 |
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer |
NCT04486755 |
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) |
NCT04457232 |
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation |
NCT03569280 |
Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients |
NCT02884648 |
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery |
NCT05168618 |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial |
NCT04886531 |
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers |
NCT05496959 |
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study |
NCT05226663 |
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer |
NCT05660083 |
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) |
NCT03677739 |
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families |
NCT02334579 |
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer |
NCT04174352 |
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer |
NCT05278871 |
Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors |
NCT03833921 |
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer |
NCT03955627 |
REJOIN Trial for Older Breast Cancer Survivors |
NCT04978675 |
An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer |
NCT04013854 |
Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab |
NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
NCT05161260 |
Breathwork App for Cancer Survivors |
NCT05386719 |
Cardiometabolic Screening Program |
NCT03847311 |
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients |
NCT03936478 |
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer |
NCT00969111 |
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy |
NCT02361320 |
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer |
NCT04386057 |
LY3214996 +/- HCQ in Pancreatic Cancer |
NCT05376878 |
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis |
NCT03407417 |
A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care |
NCT04454528 |
BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy |
NCT04493333 |
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors |
NCT05069038 |
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy |
NCT04738292 |
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study) |
NCT03275974 |
Glutamine PET Imaging Colorectal Cancer |
NCT04887805 |
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer |
NCT05703178 |
WWeb-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia |
NCT04203641 |
L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer |
NCT05568472 |
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study |
NCT05034627 |
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
NCT04365569 |
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program |
NCT04923542 |
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases |
NCT04724499 |
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy |
NCT04716725 |
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer |
NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
NCT04926181 |
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer |
NCT04870515 |
Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study |
NCT03825289 |
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer |
NCT05341349 |
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases |
NCT04998682 |
Prospective Evaluation of Targeted Axillary Dissection (TAD) |
NCT04734730 |
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer |
NCT04777071 |
An Investigational Scan (68Ga-PSMA-11 PET/CT) for the Imaging of Prostate Cancer |
NCT05557877 |
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer |
NCT04636710 |
Refining Local-Regional Therapy for IBC |
NCT04267887 |
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer |
NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
NCT03873805 |
PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer |
NCT03769415 |
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA |
NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
NCT04116073 |
INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer |
NCT04753879 |
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. |
NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer |
NCT04123470 |
A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma |
NCT04539808 |
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer |
NCT01802346 |
Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer |
NCT04983342 |
Apollo Device for Metastatic Breast Cancer (MBC) |
NCT03263429 |
Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer |
NCT02204098 |
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy |
NCT04631744 |
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
NCT03650894 |
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients |
NCT02965755 |
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins |
NCT05498272 |
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations |
NCT04215029 |
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans |
NCT04985565 |
Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer |
NCT03543189 |
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy |
NCT02106598 |
Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases |
NCT03987217 |
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients |
NCT05513742 |
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer |
NCT03727789 |
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma |
NCT05483023 |
18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy |
NCT03175432 |
Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases |
NCT02905578 |
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) |
NCT05413421 |
Study of ORIC-944 in Patients With Metastatic Prostate Cancer |
NCT03458234 |
RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy |
NCT03725761 |
IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy |
NCT04888975 |
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery |
NCT04106856 |
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER) |
NCT03460067 |
Omission of Radiation in Patients With Her-2 Positive Breast Cancer |
NCT04995978 |
Insulin Resistance and Androgen Deprivation Therapy |
NCT03856658 |
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases |
NCT04668976 |
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma |
NCT05447910 |
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT04379414 |
YES Study - Newly Diagnosed/Metastatic Intervention |
NCT01985828 |
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer |
NCT05436808 |
Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer |
NCT02476786 |
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score |
NCT04587128 |
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC |
NCT04947254 |
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer |
NCT05694559 |
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics |
NCT03285412 |
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer |
NCT04356729 |
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma |
NCT04658849 |
Insulin Resistance Following ADT for Prostate CA |
NCT05505045 |
Metacognitive Strategy Training in Cancer-related Cognitive Impairment |
NCT03440554 |
Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization |
NCT05036681 |
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma |
NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. |
NCT05241860 |
Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) |
NCT03772834 |
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer |
NCT04614194 |
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib |
NCT05281471 |
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Platinum-doublet + Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (OnPrime, GOG-3076) |
NCT04263025 |
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft |
NCT04120246 |
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer |
NCT05219695 |
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) |
NCT05523154 |
Nanopore Sequencing for Detecting Bacteria in Bile and Preventing Surgical Site Infections in Patients Undergoing Surgery for Benign or Malignant Pancreatic Tumors |
NCT02531932 |
Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer |
NCT05323955 |
Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib |
NCT04955743 |
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma |
NCT04973930 |
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer |
NCT04088708 |
Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors |
NCT04727632 |
[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial |
NCT05551117 |
MGC018 Versus Androgen Receptor Axis-targeted Therapy in Participants With Metastatic Castration Resistant Prostate Cancer |
NCT04191421 |
Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer |
NCT05560685 |
SMART-ER: Symptom Monitoring With Patient-reported Outcomes |
NCT04947917 |
Axillary Lymph Node Tattoo Marking Study |
NCT04493060 |
Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer |
NCT02538484 |
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects |
NCT05155046 |
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy |
NCT04731844 |
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer |
NCT04318028 |
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer |
NCT05121545 |
Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors |
NCT05525806 |
Clinical Utility Study for MyProstateScore+ |
NCT05381103 |
PSMA-PET to Guide Prostatectomy |
NCT03503344 |
Apalutamide With or Without Stereotactic Body Radiation Therapy in Treating Participants With Castration-Resistant Prostate Cancer (PILLAR) |
NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
NCT05038332 |
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) |
NCT04982536 |
Assessment of VMCore Biopsy Versus Standard of Care Biopsy |
NCT03999515 |
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer |
NCT03033225 |
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study |
NCT04867603 |
Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions |
NCT03685331 |
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer |
NCT05384119 |
Study of TTI-101 in Combination for Participants With Metastatic Hormone Receptor-Positive and Human Epithelial Receptor 2 (HER2)-Negative Breast Cancer |
NCT04607135 |
ARFI Imaging for Targeted Prostate Biopsy |
NCT04940299 |
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma |
NCT05113537 |
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
NCT04656678 |
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer |
NCT04394676 |
The Impact of Low Pressure Pneumo in RARP II |
NCT03269526 |
BATs Treatment for Pancreatic Cancer, Phase Ib/II |
NCT05176756 |
RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) |
NCT01984138 |
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy |
NCT04477343 |
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
NCT04908254 |
A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema |
NCT04233385 |
Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery |
NCT03546686 |
Peri-Operative Ipilimumab+Nivolumab and Cryoablation in Women With Triple-negative Breast Cancer |
NCT03575832 |
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners |
NCT04648904 |
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer |
NCT04348747 |
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer |
NCT03608631 |
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation |
NCT05243862 |
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. |
NCT02307058 |
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy |
NCT03995082 |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
NCT03824652 |
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy |
NCT04030559 |
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects |
NCT05045066 |
Differences in Immunological Effects of Vitamin D Replacement Among African American Prostate Cancer Patients With Localized Versus Metastatic Disease |
NCT04750473 |
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer |
NCT05618613 |
Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer |
NCT05340673 |
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer |
NCT04986579 |
Scalp Cooling in MBC |
NCT05409664 |
Moving Forward Together 4 |
NCT03449108 |
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas |
NCT05452681 |
A QoL Intervention for Young African American Breast Cancer Survivors |
NCT04305236 |
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer |
NCT04871139 |
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer |
NCT05458674 |
A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer |
NCT05230810 |
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. |
NCT03983577 |
Efficacy of Point Of Service Testing in MBC |
NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
NCT05037500 |
Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
NCT05591547 |
Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen for patIents With Favorable Risk breaSt cancEr |
NCT04049214 |
Perioperative Mindfulness Proposal |
NCT03120624 |
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Patients With Stage IV or Recurrent Endometrial Cancer |
NCT03387553 |
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer |
NCT04030507 |
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer |
NCT05361174 |
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer |
NCT04761614 |
Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer |
NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
NCT05114798 |
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers |
NCT05674578 |
Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors |
NCT05025059 |
Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer |
NCT03880422 |
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors |
NCT03990610 |
An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction |
NCT03844750 |
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases |
NCT04715958 |
Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation |
NCT04848337 |
Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer |
NCT05243056 |
A Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast Cancer |
NCT04692818 |
3D Ultrasound Breast Imaging |
NCT03955991 |
VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer) |
NCT04791384 |
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer |
NCT05419479 |
Switch Maintenance in Pancreatic |
NCT03366155 |
Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver |
NCT04290897 |
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors |
NCT04754412 |
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study |
NCT05049746 |
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy |
NCT03812393 |
Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast |
NCT04717050 |
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity |
NCT03424850 |
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy |
NCT04849871 |
Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma |
NCT03785288 |
Vaginal Cuff Brachytherapy Fractionation Study |
NCT04576871 |
Re-treatment 225Ac-J591 for mCRPC |
NCT04249622 |
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer |
NCT05388877 |
E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma |
NCT05298605 |
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women |
NCT05364450 |
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors |
NCT04207359 |
Effects of Creatine Supplementation in Breast Cancer Survivors |
NCT04022772 |
Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer |
NCT05095207 |
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer |
NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
NCT05617755 |
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer |
NCT04454086 |
Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors |
NCT02436993 |
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab |
NCT04445844 |
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study |
NCT05631873 |
Colonoscopy Screening: Setting Epic Follow-up Times |
NCT05471414 |
IIT Whole-Food Plant-Based Diet (WFPBD) |
NCT04870034 |
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer |
NCT04875728 |
The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma |
NCT04049695 |
Improving Cognition After Cancer |
NCT04524702 |
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer |
NCT04890054 |
Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC |
NCT03796559 |
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes |
NCT04139993 |
RBX7455 Before Surgery for the Treatment of Operable Breast Cancer |
NCT02754752 |
Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment |
NCT04205903 |
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer |
NCT05092477 |
Integrated Intervention for Breast Cancer Survivors With Diabetes |
NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
NCT00625417 |
Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors |
NCT04719273 |
Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer |
NCT05455658 |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
NCT03987386 |
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer |
NCT04754425 |
Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer |
NCT04535323 |
Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer |
NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer |
NCT05319873 |
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer |
NCT03554083 |
NeoACTIVATE: Neoadjuvant Therapy for Patients With High Risk Stage III Melanoma |
NCT03554044 |
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer |
NCT04499950 |
Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study |
NCT04471974 |
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT04673448 |
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer |
NCT05177796 |
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer |
NCT03298945 |
Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens |
NCT04645810 |
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence |
NCT05162846 |
Methods for Increasing Genetic Testing Uptake in Michigan |
NCT03207529 |
Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer |
NCT04592237 |
Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer |
NCT04374747 |
Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk |
NCT05473026 |
Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors |
NCT03897270 |
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects |
NCT04951492 |
Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma |
NCT03535727 |
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer |
NCT03796767 |
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer |
NCT04428905 |
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer |
NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
NCT05183828 |
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer |
NCT03657069 |
Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy |
NCT04267939 |
ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer |
NCT05204147 |
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Positive Advanced Colorectal Cancer |
NCT03216421 |
Intraoperative Radiation Therapy (IORT) in DCIS |
NCT04016376 |
Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction |
NCT05453630 |
Colonoscopy Outreach for Rural Communities Aim 2 |
NCT04839614 |
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia |
NCT04762979 |
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer |
NCT03698162 |
Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases |
NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
NCT05428007 |
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma |
NCT04843306 |
Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients |
NCT05538897 |
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers |
NCT03844620 |
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer |
NCT05508906 |
Phase 1b Combo w/ Ribociclib and Alpelisib |
NCT04796818 |
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response |
NCT04789486 |
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer |
NCT04481113 |
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer |
NCT04484909 |
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer |
NCT05130060 |
A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer |
NCT04085510 |
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania |
NCT03572283 |
Bethanechol Prior to Pancreatic Surgery |
NCT05141513 |
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma |
NCT02535078 |
Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Cutaneous Melanoma |
NCT04616183 |
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer |
NCT04017650 |
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer |
NCT05669482 |
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer |
NCT02912572 |
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer |
NCT03991962 |
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma |
NCT03910387 |
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer |
NCT05286814 |
M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma |
NCT03704662 |
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma |
NCT03087071 |
Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer |
NCT02863783 |
EUS Fiducial for Pancreas Surgery |
NCT05200559 |
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors |
NCT04599218 |
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer |
NCT02451982 |
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas |
NCT04253483 |
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer |
NCT05712668 |
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors |
NCT04485767 |
RESIST-ADT (Androgen Deprivation Therapy) |
NCT05254171 |
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer |
NCT03384836 |
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery |
NCT02949284 |
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery |
NCT04616534 |
Testing the Addition of an Anti-cancer Drug, BAY 1895344 ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors |
NCT05086705 |
EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer |
NCT02689427 |
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer |
NCT04683315 |
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples |
NCT04777786 |
Early Rehabilitation for Breast Cancer - A Randomized Control Trial |
NCT05032040 |
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies |
NCT04390399 |
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
NCT02946697 |
A Culturally Sensitive Social Support Intervention |
NCT05646316 |
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer |
NCT03449238 |
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients |
NCT02672917 |
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies |
NCT04763902 |
Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer |
NCT04927663 |
11C-YJH08 PET Imaging for the Detection of Glucocorticoid Receptor Expression in Patients With Metastatic Prostate Cancer |
NCT04940286 |
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer |
NCT03213041 |
Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer |
NCT04705363 |
A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans |
NCT05041101 |
Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer |
NCT04461509 |
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy |
NCT03955510 |
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis |
NCT04959474 |
SABR-CaRe in Early Stage Breast Cancer |
NCT03737370 |
Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer |
NCT04763824 |
KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice |
NCT03345420 |
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer |
NCT04313114 |
The PRIME-CRC Trial to Promote CRC Screening in Rural Communities |
NCT03768492 |
Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy |
NCT04915508 |
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy |
NCT03640208 |
Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans |
NCT03550885 |
Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk |
NCT05241249 |
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma |
NCT05038137 |
Time Restricted Eating on Cancer Risk |
NCT04711161 |
First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers. |
NCT04763915 |
Improving Care After Inherited Cancer Testing |
NCT05012176 |
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors |
NCT05094102 |
Intraoperative Evaluation of Axillary Lymphatics |
NCT05365893 |
PHL Treatment in Pancreatic Cancer |
NCT03146962 |
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies |
NCT03484299 |
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma |
NCT04407247 |
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma |
NCT02598349 |
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas |
NCT05055323 |
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer |
NCT04005690 |
Targeted PARP or MEK/ERK Inhibition in Patients With Pancreatic Cancer |
NCT03540017 |
HIPEC After Initial CRS in Patients Who Have Received NACT |
NCT04750941 |
Study of Copanlisib and Ketogenic Diet |
NCT03202316 |
Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer |
NCT02452008 |
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer |
NCT04990609 |
Endoscopic Ultrasound PANcreatic CAncer RaDIofrequeNcy AbLation |
NCT04981834 |
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer |
NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
NCT03592888 |
DC Vaccine in Pancreatic Cancer |
NCT04646434 |
Brain and Pelvic Floor Muscle Activity of Patients Undergoing Robot-Assisted Radical Prostatectomy |
NCT05010759 |
Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer |
NCT03716739 |
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency |
NCT04396808 |
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer |
NCT04599140 |
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial |
NCT04194554 |
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer |
NCT02484404 |
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... |
NCT03701581 |
4-aminopyridine Treatment for Nerve Injury |
NCT03796273 |
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases |
NCT05366842 |
Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care |
NCT04304001 |
Test Up Now Education Program |
NCT03073785 |
Hypofractionated Stereotactic Body Radiation Therapy and Fluorouracil or Capecitabine With or Without Zoledronic Acid in Treating Patients With Locally Advanced Pancreatic Cancer |
NCT04837209 |
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer |
NCT03907527 |
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT04616248 |
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors |
NCT04975217 |
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer |
NCT03885284 |
Study of Proton Therapy in Adjuvant Pancreatic Cancer |
NCT03507608 |
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression |
NCT05114421 |
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients |
NCT03865875 |
Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program |
NCT05456685 |
IMGN853 With Carboplatin in Second-line Treatment of FRα Expressing, Platinum-sensitive Epithelial Ovarian Cancer |
NCT05519449 |
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) |
NCT05304936 |
HCW9218 for Advanced Pancreatic Cancer |
NCT05289830 |
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer |
NCT05335993 |
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. |
NCT05375604 |
A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From Primary Gastric Cancer and Colorectal Cancer (CRC) |
NCT02335671 |
Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy |
NCT04594772 |
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma |
NCT03732950 |
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer |
NCT04606914 |
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT05077800 |
FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer |
NCT03851237 |
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy |
NCT05595213 |
Wrist Cooling for Hot Flashes Clinical Trial |
NCT04387071 |
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma |
NCT05458544 |
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application |
NCT05098327 |
Pioglitazone and Insulin Resistance in ADT |
NCT02095184 |
GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients |
NCT04965311 |
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy |
NCT05271318 |
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Ovarian Cancer |
NCT04143516 |
Tissue Analysis After Thermal Ablation for Colon Cancer Liver Metastases Leading to Immediate Retreatment |
NCT04976257 |
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion |
NCT04305145 |
Infliximab for Treatment of Ipilimumab Colitis |
NCT05142358 |
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose |
NCT04879940 |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
NCT02757859 |
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery |
NCT03642067 |
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer |
NCT02124421 |
HOT: HIPEC in Ovarian Cancer as Initial Treatment |
NCT04514692 |
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging |
NCT03781154 |
Predictors of Physical Activity Maintenance in Colorectal Cancer Survivors |
NCT03008408 |
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma |
NCT04670445 |
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer |
NCT01794403 |
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer |
NCT01407263 |
Trial of Modifications to Radical Prostatectomy |
NCT03428581 |
Preventing Lymphedema in Axillary Lymph Node Dissection |
NCT03419585 |
The "PC-LIGHT" Study |
NCT05296421 |
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer |
NCT04662879 |
Early Detection Initiative for Pancreatic Cancer |
NCT03991741 |
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors |
NCT02422641 |
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis |
NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
NCT05336266 |
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma |
NCT05386108 |
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer |
NCT04527900 |
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach |
NCT03573648 |
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer |
NCT05588609 |
Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers |
NCT03290677 |
Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy |
NCT04906200 |
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors |
NCT04862585 |
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel |
NCT03878849 |
Investigation of 2X-121 in Patients With Advanced Ovarian Cancer Selected by the 2X-121 DRP® |
NCT05301114 |
Social Risk Factors and Discrimination in Cancer Survivorship |
NCT03784677 |
SOR-C13 in Treating Patients With Advanced Refractory Solid Tumors |
NCT04896320 |
Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. |
NCT01712815 |
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer |
NCT02891538 |
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients |
NCT04993313 |
Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study |
NCT05039801 |
IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors |
NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
NCT05455619 |
Evexomostat Plus Alpelisib and Fulvestrant in Postmenopausal Women at Risk for Hyperglycemia With Breast Cancer |
NCT05040568 |
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD) |
NCT05464810 |
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT03789097 |
Vaccination With Flt3L, Radiation, and Poly-ICLC |
NCT05451849 |
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer |
NCT05366699 |
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy |
NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
NCT05130580 |
Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction |
NCT04925817 |
3D Ultrasound Microvessel Imaging for Breast Masses |
NCT05103683 |
First in Human Study of TORL-1-23 in Participants With Advanced Cancer |
NCT05086731 |
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer |
NCT04849858 |
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures |
NCT05412953 |
Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain |
NCT05296512 |
Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer |
NCT04943536 |
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer |
NCT05163223 |
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer |
NCT04175431 |
Fluciclovine (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study |
NCT04683731 |
Helping Patients and Providers Make Better Decisions About Colorectal Cancer Screening |
NCT04294225 |
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer |
NCT05368428 |
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer |
NCT04946370 |
Maximizing Responses to Anti-PD1 Immunotherapy With PSMA-targeted Alpha Therapy in mCRPC |
NCT04514484 |
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV |
NCT04837833 |
An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma |
NCT05056077 |
Improving Nutrition and Physical Activity for Colorectal Cancer Survivors (Tools To Be Fit) |
NCT05251714 |
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer |
NCT01492972 |
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer |
NCT04905082 |
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics |
NCT04899908 |
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases |
NCT04743934 |
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer |
NCT05369000 |
Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer |
NCT04009044 |
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast |
NCT04000880 |
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health |
NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study |
NCT05194735 |
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors |
NCT03642990 |
NR in Chemo-induced Peripheral Neuropathy |
NCT03179904 |
FASN Inhibitor TVB-2640 and Trastuzumab in Combination With Paclitaxel or Endocrine Therapy for the Treatment of HER2 Positive Metastatic Breast Cancer |
NCT04946864 |
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer |
NCT03361735 |
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer |
NCT03715959 |
Nipple Aspirate Fluid in Detecting Breast Cancer |
NCT02926690 |
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer |
NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
NCT05488444 |
A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care |
NCT05428709 |
Women In Steady Exercise Research - Window of Opportunity for Exercise and Tumor Biology |
NCT05316324 |
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction |
NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
NCT04387227 |
Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
NCT05206331 |
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study |
NCT05181722 |
Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic |
NCT05178927 |
UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization |
NCT04331041 |
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma |
NCT04603911 |
RCT Comparing ESPB Solutions in Breast Surgery |